Position in RARE
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$22,965,012
+$4,579,180 QoQ
Shares Held
1,096,182
+37.1% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Candriam S.C.A. holds $1,920,933,361 across 79 Biotechnology names. RARE ranks #29 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
186,388 | $144,010,824 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
228,915 | $102,219,704 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
259,731 | $77,132,315 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
224,330 | $74,224,067 | |
| 5 | INSM |
INSMED Inc
|
401,735 | $65,691,707 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
1,516,297 | $58,362,271 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
580,677 | $56,470,838 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,001,976 | $55,454,735 |
All Filings in RARE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,965,012 | 1,096,182 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $18,385,832 | 799,384 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $22,701,797 | 754,714 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $19,135,068 | 526,267 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $26,361,495 | 728,017 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $28,365,991 | 674,257 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $39,612,260 | 713,092 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $28,315,516 | 688,942 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $24,166,603 | 517,597 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $7,100,313 | 148,480 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,763,962 | 49,480 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,282,512 | 49,480 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,431,463 | 60,635 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,292,408 | 49,480 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,048,966 | 49,480 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,951,976 | 49,480 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $3,593,237 | 49,480 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,160,773 | 49,480 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,462,601 | 49,480 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $4,717,918 | 49,480 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $11,207,125 | 98,429 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $13,625,526 | 98,429 | Shares | Sole | 2021-01-22 | |
| 2020-03-31 | $5,398,245 | 121,500 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||